Stoke Therapeutics Inc. STOK
$29.39
▲ +1.57% 24H
About
Stoke Therapeutics Inc. is a biotechnology company focused on developing RNA-based medicines to treat the underlying causes of severe genetic diseases. It employs its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) platform, which uses antisense oligonucleotides to upregulate protein expression from he…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees170
TickerSTOK
Statistics
Market Cap$1.83B
Revenue (TTM)$184.4M
Net Income-$6.9M
Net Margin-3.7%
EPS$-0.12
P/E48.81
P/S57.00
P/B4.63
EV/EBITDA-7.81
ROE-45.6%
Dividend Yield—
Price$29.39
Data: Twelve Data · Revenue = mcap / P/S